Previous 10 | Next 10 |
2024-06-25 12:12:34 ET More on Eli Lilly Eli Lilly: Throwing Its Weight Around - But, For How Long? (Technical Analysis) Eli Lilly: The Party Is Probably Nearing The End Eli Lilly And Alzheimer's Disease: The Paucity Of Progress Eli Lilly collaborates with Op...
2024-06-25 11:08:09 ET Eli Lilly and Company ( NYSE: LLY ) said on Tuesday that it is collaborating with Microsoft ( MSFT ) backed-OpenAI that will help leverage generative AI to invent novel antimicrobials to treat drug-resistant pathogens.... Read the full article on See...
Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria PR Newswire INDIANAPOLIS , June 25, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced a collaboration with OpenAI that will allow Lilly to leverage OpenAI's...
2024-06-25 06:30:00 ET Summary Six years ago, Apple became a $1 trillion company, not long before oil titan Saudi Aramco publicly debuted with a 13-digit market capitalization. Chipmaker Broadcom is riding an artificial intelligence wave. Eli Lilly is also on its way, thanks to th...
2024-06-24 15:56:56 ET Here's why Fundstrat's Tom Lee says the S&P 500 may reach 15,000 by 2030 ' Inflation is not the only risk we face', says Fed's Mary Daly The Fed could be running the risk of delaying cuts too long - Pantheon Macroeconomics S&P 500 E...
2024-06-24 15:17:13 ET More on Inspire Medical, ResMed Inspire Medical Systems: A Post Q1 Assessment ResMed, Philips under pressure as Eli Lilly seeks sleep indication for weight loss drug Inspire Medical Systems, Inc. (INSP) Q1 2024 Earnings Call Transcript ...
2024-06-24 14:51:58 ET More on Novo Nordisk Novo Nordisk: Leading The Fight Against Diabetes And Obesity Novo Nordisk: The Market Is Right, Don't Fight Against It Novo Nordisk: Not The Best Investment Right Now, But A Great Case Study Lilly, Novo Nordisk to d...
2024-06-24 13:05:06 ET Summary Zealand Pharma A/S petrelintide showed promising results in a phase 1b study, with patients achieving up to 8.6% weight loss over 16 weeks at the highest dose. The global obesity market could reach $77 billion in 2030. Survodutide, dapiglutide, a...
Eli Lilly and Company (NYSE: LLY) is one of today's top gainers. The company's shares have moved 1.95% on the day to $901.08. Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Hu...
Lilly Declares Third-Quarter 2024 Dividend PR Newswire INDIANAPOLIS , June 24, 2024 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2024 of $1.30 per share on outstanding common stoc...
News, Short Squeeze, Breakout and More Instantly...
2024-07-27 07:15:00 ET According to some research, bull markets tend to last an average of 2.6 years. The one we are currently experiencing has been going on for almost two years -- maybe it will soon end, maybe it won't. Equities that can perform well throughout bull runs might be good to ...
2024-07-26 07:45:00 ET Over the last 18 months, the stock market has been incredibly generous to investors. Since January 2023, the S&P 500 has soared 45%, while the tech-heavy Nasdaq Composite has rocketed by 72%. Outside of the technology industry, investors have also foun...
2024-07-25 19:06:06 ET It wasn't so long ago when Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) stocks were flying high thanks to their hotly popular weight loss drugs (Wegovy/Ozempic for Novo Nordisk and Zepbound/Mounjaro for Lilly). In the pharmaceutical industry,...